Clinical Fellow for Vitreoretinal (VR)

VITREORETINAL OPHTHALMOLOGY FELLOWSHIP The VITREORETINAL fellowship is available at the John Radcliffe Hospital. This post is suitable for doctors who have completed their training but seek experience in VITREORETINAL SURGERY prior to obtaining a consultant appointment. It is not a post that is approved for training by the Royal College of Ophthalmologists. Candidates are welcome to visit the department and are invited to contact Consultant, Mr Sher Aslam Consultant Ophthalmologist at the Oxford Eye Hospital, Oxford University Hospitals NHS Trust, The John Radcliffe (Tel: Oxford (01865 234567). Applications are invited for this fellowship training post in Ophthalmology based at the John Radcliffe Hospital Oxford, available from February 2027 for a 12 month Fixed Term.

Candidates should be post CCT or equivalent. This post is suitable for doctors who have completed their training but seek experience in vitreoretinal surgery prior to obtaining a consultant appointment. It is not an approved training post. Candidates are welcome to visit the department and are invited to contact Mr Sher Aslam Consultant Ophthalmologist at the Oxford Eye Hospital, Oxford University Hospitals NHS Trust, The John Radcliffe (Tel: Oxford 01865 234567). (PA contact karen.finch@ouh.nhs.uk). Oxford University Hospitals NHS Trust provides a regional service for vitreoretinal surgery for a catchment population of 1 million patients, caring for both children and adults. The full range of vitreoretinal conditions are treated, in addition to novel therapies, including gene therapy, subretinal electronic implants, robotic surgery, and Paediatric vitreoretinal surgery. In addition, we have a comprehensive range of medical retina services, covering complex macular disease clinics, a focus on OCT training /teaching as well as retinovascular diseases and genetics. As a major international ophthalmic research unit, we strongly encourage research and service development projects. Here at Oxford, we participate and lead in clinical trials supported by a dedicated clinical trials unit for Ophthalmology. This department runs studies in macular telangectasia, gene therapy for retinal genetic diseases and uveitis.